期刊文献+

紫花牡荆素抑制乳腺癌MCF-7细胞增殖与侵袭能力的研究

Casticin inhibits proliferation and invasion of breast cancer MCF-7 cells
原文传递
导出
摘要 目的观察紫花牡荆素对乳腺癌MCF-7细胞株增殖与侵袭能力的影响并探讨其分子机制。方法应用四甲基偶氮唑蓝(MTT)比色法与侵袭实验检测紫花牡荆素对MCF-7细胞增殖与侵袭能力的影响,应用反转录PCR、Western blot法、Tunel法检测紫花牡荆素对基因表达、蛋白表达、细胞凋亡的影响。结果不同浓度紫花牡荆素均抑制MCF-7细胞增殖水平,同未加药对照组比较差异均有统计学意义(P〈0.05),5、10、20μmol/L紫花牡荆素作用后,MCF-7细胞迁移数与未处理组相比分别降低20.3%、44.4%和50.3%(P〈0.05)。以10μmol/L紫花牡荆素处理后,凋亡细胞数增多,可以上调Bax与Caspase-3蛋白的表达水平,下调基质金属蛋白酶(MMP)-2与MMP-9的mRNA和蛋白表达水平。结论紫花牡荆素对于乳腺癌细胞恶性增殖与侵袭能力具有显著抑制作用。 Objective To investigate the effects of casticin on proliferation and invasion on human breast cancer MCF-7 cells. Methods MTT assay and invasion assay were performed in MCF-7 cells treated with casticin, respectively. The expression of Bax, Caspase-3, MMP-2 and MMP-9 was analyzed by RT-PCR and Western blot. Results Casticin inhibited MCF-7 cells proliferation and invasion in a dose-dependent manner (P 〈 0.05). Additionally, Bax and Caspase-3 expression was increased in MCF-7 cells treated with casticin, whereas MMP-2 and MMP-9 were down-regulated. Conclusion Casticin may play a critical role in inhibiting breast tumor cell proliferation and invasion, reinforcing its potential in clinical application.
出处 《肿瘤研究与临床》 CAS 2012年第8期524-526,共3页 Cancer Research and Clinic
关键词 紫花牡荆素 乳腺肿瘤 细胞增殖 肿瘤侵润 Casticin Breast neoplasms Cell proliferation Neoplasm invasiveness
  • 相关文献

参考文献8

  • 1Schneider M. Zuckerman IH. Onukvvugha E. et al. Chemotherapy treatment and survival in older 'vomen with estrogen rereptor-negative metastafir hreast ranoer: a population-based analysis. J Am Geriatr Soc, 2011,59:637-646.
  • 2Haidara K, Zamir L, Shiet al. The flavonoid Casticin hasmultiple mechiinisms of rumor cytotoxicity action. Cancer Lett. 2006? 242: 180-190.
  • 3Tomita N. BCL2 and M YC dual-hit lymphoma/leukemia. J Clin Exp Hematop, 2011, 51: 7-12.
  • 4Freitas S, Costa S, Azevedfi C, et al. Flavonoids inhibit angiogenif cytokine production Dv human glioma cells. Phytother lies, 2011, 25: 916-921.
  • 5Chen D Cao J, Tian L, et al. Induction of apoptosis by casticin in cervical cancer cells ihrough reactive oxygen species-mediated mitochondrial signaling pathways. Oncol Rep, 2011,26: 1287-1294.
  • 6Park KS, Kim SJ, Kim KH. et al. Clinical characteristifis of TIMP2. MMP2. and MMP9 gene polymorphisms in t'oloret tal cancer. J Gastroenterol Hepatol, 2()11, 26: 391-397.
  • 7黄杰雄,张永海,林莹,等.MMP-2、MMP-9在胃癌组织中的表达及其临床意义.肿瘤研究与临床,2011,23:22-24.
  • 8郭德超,安慧敏,郭希民,戴华卫.人类乳腺癌组织中血管内皮生长因子和基质金属蛋白酶-2的表达[J].肿瘤研究与临床,2008,20(1):20-22. 被引量:1

二级参考文献15

  • 1Miyake H,Hrar I,Yodhimura K. Introduction of basic fibroblast growth factor gene into mouse renal cell carcinoma cell line enhances its metastatic potential[J].Cancer Research,1996,(10):2240-2445.
  • 2Leffler SG,Chew FS. CT-guided percutaneous biopsy of sclerotic bone lesions:diagnostic yield and accuracy[J].American Journal of Roentgenology,1999,(05):1389-1392.
  • 3Shweiki D,Itin A,Soffer D. Vascular endothelial growth factor induced by bypoxia may mediate hypoxia-intiated angiogenesis[J].Nature,1992,(6398):843-845.doi:10.1038/359843a0.
  • 4Shimizu M,Saitoh Y,Itoh H. Immunohistochemical staining of Haras oncogene product in normal,benign and malignant human pancreatic tissues[J].Human Pathology,1990,(06):607-612.doi:10.1016/S0046-8177(96)90006-4.
  • 5Yancopoulos GD,Davis S,Gale NW. Vascular specific growth factor and blood vessel formation[J].NATURE,2000,(6801):242-248.doi:10.1038/35025215.
  • 6Tordjman R,Delaire S,Plouet J. Erythroblasts are a source of angiogenic factors[J].Blood,2001,(07):1968-1974.doi:10.1182/blood.V97.7.1968.
  • 7Karkkainen MJ,Petrova TV. Vascular endothelial growth factor receptors in the regulation of angiogensis and lymphangiogenesis[J].Oncogene,2000,(49):5598.doi:10.1038/sj.onc.1203855.
  • 8Kakeji Y,Maehara Y,Sumiyoshi Y. Angiogenesis as a target for gastric cancer[J].Surgery,2002,(z1):548.
  • 9Mook OR,Fredenks WM,VanNOOrden CJ. The role of gelatinases in colorectal cancer progression and metastasis[J].Bilchin Bilphys Acta,2004,(02):69-89.doi:10.1016/j.bbcan.2004.09.006.
  • 10Moran A,Iniesta P,Garcia-Aranda C. Clinical relevance of MMP-9,MMP-2,MMP-1 and TMP-2 in colorectal cancer[J].Oncology Reports,2005,(01):115-120.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部